297 related articles for article (PubMed ID: 9927572)
1. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus.
Hammond SA; Cook SJ; Falo LD; Issel CJ; Montelaro RC
Virology; 1999 Feb; 254(1):37-49. PubMed ID: 9927572
[TBL] [Abstract][Full Text] [Related]
2. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
Raabe ML; Issel CJ; Montelaro RC
Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus.
Hammond SA; Raabe ML; Issel CJ; Montelaro RC
Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520
[TBL] [Abstract][Full Text] [Related]
4. Immunization with a recombinant envelope protein (rgp90) of EIAV produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement.
Raabe ML; Issel CJ; Cook SJ; Cook RF; Woodson B; Montelaro RC
Virology; 1998 May; 245(1):151-62. PubMed ID: 9614876
[TBL] [Abstract][Full Text] [Related]
5. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.
Lin YZ; Shen RX; Zhu ZY; Deng XL; Cao XZ; Wang XF; Ma J; Jiang CG; Zhao LP; Lv XL; Shao YM; Zhou JH
Antiviral Res; 2011 Nov; 92(2):292-304. PubMed ID: 21893100
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus.
Issel CJ; Horohov DW; Lea DF; Adams WV; Hagius SD; McManus JM; Allison AC; Montelaro RC
J Virol; 1992 Jun; 66(6):3398-408. PubMed ID: 1316455
[TBL] [Abstract][Full Text] [Related]
7. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.
Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J
Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668
[TBL] [Abstract][Full Text] [Related]
8. A pilot study on an attenuated Chinese EIAV vaccine inducing broadly neutralizing antibodies.
Meng Q; Lin Y; Ma J; Ma Y; Zhao L; Li S; Liang H; Zhou J; Shen R; Zhang X; Shao Y
Arch Virol; 2011 Aug; 156(8):1455-62. PubMed ID: 21499906
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein.
Wang SZ; Rushlow KE; Issel CJ; Cook RF; Cook SJ; Raabe ML; Chong YH; Costa L; Montelaro RC
Virology; 1994 Feb; 199(1):247-51. PubMed ID: 8116252
[TBL] [Abstract][Full Text] [Related]
10. Genetic immunization with codon-optimized equine infectious anemia virus (EIAV) surface unit (SU) envelope protein gene sequences stimulates immune responses in ponies.
Cook RF; Cook SJ; Bolin PS; Howe LJ; Zhou W; Montelaro RC; Issel CJ
Vet Microbiol; 2005 Jun; 108(1-2):23-37. PubMed ID: 15885929
[TBL] [Abstract][Full Text] [Related]
11. Immunopathogenesis of equine infectious anemia lentivirus disease.
McGuire TC; O'Rourke KI; Perryman LE
Dev Biol Stand; 1990; 72():31-7. PubMed ID: 2178127
[TBL] [Abstract][Full Text] [Related]
12. Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses.
McGuire TC; Zhang W; Hines MT; Henney PJ; Byrne KM
Virology; 1997 Nov; 238(1):85-93. PubMed ID: 9375012
[TBL] [Abstract][Full Text] [Related]
13. A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses.
Li F; Craigo JK; Howe L; Steckbeck JD; Cook S; Issel C; Montelaro RC
J Virol; 2003 Jul; 77(13):7244-53. PubMed ID: 12805423
[TBL] [Abstract][Full Text] [Related]
14. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge.
Fraser DG; Leib SR; Zhang BS; Mealey RH; Brown WC; McGuire TC
Clin Diagn Lab Immunol; 2005 Aug; 12(8):983-93. PubMed ID: 16085917
[TBL] [Abstract][Full Text] [Related]
16. Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.
Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Kong X; Zhou J
Arch Virol; 2011 Feb; 156(2):353-7. PubMed ID: 21136127
[TBL] [Abstract][Full Text] [Related]
17. [Induction of EIAV-specific cellular immune response by attenuated EIAV vaccine].
Zhang XY; Li HM; Liang H; Shen T; Ma Y; Xiang WH; Shen RX; Shao YM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):115-8. PubMed ID: 16388761
[TBL] [Abstract][Full Text] [Related]
18. Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy.
Craigo JK; Li F; Steckbeck JD; Durkin S; Howe L; Cook SJ; Issel C; Montelaro RC
J Virol; 2005 Mar; 79(5):2666-77. PubMed ID: 15708986
[TBL] [Abstract][Full Text] [Related]
19. Fine specificity of equine infectious anaemia virus gp90-specific antibodies associated with protective and enhancing immune responses in experimentally infected and immunized ponies.
Grund CH; Lechman ER; Pezzuolo NA; Issel CJ; Montelaro RC
J Gen Virol; 1996 Mar; 77 ( Pt 3)():435-42. PubMed ID: 8601778
[TBL] [Abstract][Full Text] [Related]
20. Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?
Leroux C; Cadoré JL; Montelaro RC
Vet Res; 2004; 35(4):485-512. PubMed ID: 15236678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
